Novo Nordisk website screenshot

Novo Nordisk

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, and the world leader in diabetes care. The company also develops treatments for obesity, rare blood disorders, and growth-hormone therapy, including its widely known GLP-1 medicines Ozempic, Wegovy, and Rybelsus. Novo Nordisk does not publish a public commercial developer API. The company maintains a research GitHub organization (novonordisk-research) that releases open-source scientific computing libraries and an SDK for the Waters Empower Web API (OptiHPLCHandler) used in pharmaceutical analytical chemistry workflows.

Novo Nordisk is profiled on the APIs.io network. Tagged areas include Pharmaceutical, Healthcare, Biotechnology, Diabetes, and Obesity.

8.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
PharmaceuticalHealthcareBiotechnologyDiabetesObesityOpen Source Research

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 8.3/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.7 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/novo-nordisk: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Novo Nordisk Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Get Started 1

Portal, sign-up, and the first successful call

Build 1

SDKs, sample code, and the tooling you integrate with

Access & Security 1

Authentication, authorization, and security posture

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: novo-nordisk
name: Novo Nordisk
description: Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, and the
  world leader in diabetes care. The company also develops treatments for obesity, rare blood disorders, and growth-hormone
  therapy, including its widely known GLP-1 medicines Ozempic, Wegovy, and Rybelsus. Novo Nordisk does not publish a public
  commercial developer API. The company maintains a research GitHub organization (novonordisk-research) that releases open-source
  scientific computing libraries and an SDK for the Waters Empower Web API (OptiHPLCHandler) used in pharmaceutical analytical
  chemistry workflows.
type: Index
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/novo-nordisk.png
tags:
- Pharmaceutical
- Healthcare
- Biotechnology
- Diabetes
- Obesity
- Open Source Research
url: https://raw.githubusercontent.com/api-evangelist/novo-nordisk/refs/heads/main/apis.yml
created: '2026-05-05'
modified: '2026-05-16'
specificationVersion: '0.19'
apis: []
common:
- type: DomainSecurity
  url: security/novo-nordisk-domain-security.yml
- type: LinkedIn
  url: https://www.linkedin.com/company/novo-nordisk
- type: Website
  url: https://www.novonordisk.com/
- type: GitHubOrganization
  url: https://github.com/novonordisk-research
- type: PartnerPortal
  url: https://digitalpartnerships.novonordisk.com/
  description: Novo Nordisk Digital Partnerships portal — the public landing for would-be technology / data partners. No open
    APIs; partnership outreach only (the `developer.novonordisk.com` subdomain 301s here).
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com